WASHINGTON, DC –– By a 71-point margin, voters support the Department of Health and Human Services’ proposal to lower drug prices in Medicare Part B by implementing an International Pricing Index (80 percent support vs. 9 percent oppose). Majorities from both parties believe Democrats and Republicans in Congress should support the proposal that would lower prices for infused drugs administered in physician offices and hospitals.Importantly, 8 in 10 voters believe the proposal will result in better care or have no impact on the care they receive. Click here to read the poll.
Support for the proposed Medicare Part B reforms are widely popular.
Voters say drug prices are too high and both Congress and the President should do more to lower them.
“Voters in this country are clamoring for reforms to lower drug prices and they want officials in Washington to take action to bring prices more in line with other wealthy nations,” said David Mitchell, a Medicare beneficiary, cancer patient, and the Founder of Patients For Affordable Drugs NOW. “This proposal will lower list prices and out-of-pocket costs for patients.”
75 percent of voters support—and 50 percent strongly support—the element of the proposal that will change the way doctors are paid to administer the drugs from a percentage to a fixed fee, thereby eliminating the incentive to prescribe more expensive drugs.
The telephone survey of 1,000 likely voters was conducted by GS Strategy Group from December 11-13, 2018. 50 percent of the interviews were completed via cell phone. It has a margin of error of +/- 3.2 percent at the 95 percent confidence level.